0001062993-24-003329.txt : 20240215
0001062993-24-003329.hdr.sgml : 20240215
20240215172539
ACCESSION NUMBER: 0001062993-24-003329
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240213
FILED AS OF DATE: 20240215
DATE AS OF CHANGE: 20240215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hahne Vicky
CENTRAL INDEX KEY: 0001716043
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38207
FILM NUMBER: 24644936
MAIL ADDRESS:
STREET 1: C/O CELCUITY, 16305 36TH AVENUE N.
STREET 2: #450
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55446
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celcuity Inc.
CENTRAL INDEX KEY: 0001603454
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 16305 36TH AVENUE N
STREET 2: SUITE 100
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55446
BUSINESS PHONE: 763-392-0767
MAIL ADDRESS:
STREET 1: 16305 36TH AVENUE N
STREET 2: SUITE 100
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55446
FORMER COMPANY:
FORMER CONFORMED NAME: Celcuity LLC
DATE OF NAME CHANGE: 20140324
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2024-02-13
0001603454
Celcuity Inc.
CELC
0001716043
Hahne Vicky
16305 36TH AVENUE N.
SUITE 100
MINNEAPOLIS
MN
55446
0
1
0
0
Chief Financial Officer
0
Common Stock
16557
D
Stock Option (right to buy)
8.4000
2027-05-17
Common Stock
37500
37500
D
Stock Option (right to buy)
5.50
2028-07-05
Common Stock
3000
3000
D
Stock Option (right to buy)
5.50
2028-10-17
Common Stock
932
932
D
Stock Option (right to buy)
5.50
2029-08-12
Common Stock
3000
3000
D
Stock Option (right to buy)
5.9000
2030-08-12
Common Stock
10000
10000
D
Stock Option (right to buy)
5.50
2030-12-28
Common Stock
1122
1122
D
Stock Option (right to buy)
5.50
2031-02-02
Common Stock
1301
1301
D
Stock Option (right to buy)
5.50
2031-03-18
Common Stock
1204
1204
D
Stock Option (right to buy)
5.50
2031-04-12
Common Stock
3806
3806
D
Stock Option (right to buy)
5.50
2031-08-11
Common Stock
15000
15000
D
Stock Option (right to buy)
5.50
2031-10-27
Common Stock
821
821
D
Stock Option (right to buy)
5.50
2032-05-17
Common Stock
31930
31930
D
Stock Option (right to buy)
11.55
2033-02-16
Common Stock
5069
5069
D
Stock Option (right to buy)
9.89
2033-08-25
Common Stock
21250
21250
D
Stock Option (right to buy)
9.89
2033-08-25
Common Stock
60000
60000
D
Stock Option (right to buy)
15.03
2024-02-13
4
A
0
5530
0
A
2034-02-13
Common Stock
5530
5530
D
Includes 2,000 shares acquired on October 31, 2023 pursuant to the Issuer's Employee Stock Purchase Plan.
Fully vested.
2,500 shares vest on 8/12/21; the remaining 7,500 shares vest 1/36th per month thereafter.
280 shares vest on 12/29/21; the remaining 842 shares vest 1/36th per month thereafter.
325 shares vest on 2/2/22; the remaining 976 shares vest 1/36th per month thereafter.
301 shares vest on 3/18/22; the remaining 903 shares vest 1/36th per month thereafter.
952 shares vest on 4/12/22; the remaining 2,854 shares vest 1/36th per month thereafter.
3,750 shares vest on 8/11/22; the remaining 11,250 shares vest 1/36th per month thereafter.
205 shares vest on 10/27/22; the remaining 616 shares vest 1/36th per month thereafter.
These shares vest in equal amounts on the last day of each month over seventeen (17) months, beginning August 31, 2023.
15,000 shares vest on 8/25/24; the remaining 45,000 shares vest 1/36th per month thereafter.
These shares vest in equal amounts on the first day of each month over twelve (12) months, beginning March 1, 2024
/s/ Eric O. Madson as Attorney-in-Fact for Vicky Hahne pursuant to Power of Attorney previously filed.
2024-02-15